Comparative study in mice of the toxicity, pharmacology, and therapeutic activity of daunorubicin-DNA and doxorubicin-DNA complexes

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00253101PMID 498415
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: Plasma levels in DBA2 mice

  2004cited by this paper
• GROWTH OF STEM CELL CONCENTRATES IN DIFFUSION CHAMBERS (DC)

  1974influential reference
• Experimental leukemia chemotherapy with a "lysosomotropic" adriamycin-DNA complex.

  1974cited by this paper
• In vitro iodination of DNA. Maximizing iodination while minimizing degradation; use of buoyant density shifts for DNA-DNA hybrid isolation.

  1974cited by this paper
• Chemotherapy through lysosomes with a DNA-daunorubicin complex.

  1972cited by this paper
• Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.

  1972cited by this paper
• Iodination of nucleic acids in vitro.

  1971cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper
• A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

  1961cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers

  2020cites this paper
• Chaperonin-GroEL as a Smart Hydrophobic Drug Delivery and Tumor Targeting Molecular Machine for Tumor Therapy.

  2018cites this paper
• Synthesis and investigation of the specific activity of the DNA-doxorubicin conjugates

  2017cites this paper
• Low-density lipoprotein peptide-combined DNA nanocomplex as an efficient anticancer drug delivery vehicle.

  2015cites this paper
• ЭФФЕКТИВНОСТЬ ДНК-КОНЪЮГИРОВАННЫХ ФОРМ ДОКСОРУБИЦИНА И ЦИСПЛАТИНА ПРИ ХОЛАНГИОЦЕЛЛЮЛЯРНОЙ КАРЦИНОМЕ У КРЫС

  2014cites this paper
• Synthesis and Biological Activities of a 3′-Azido Analogue of Doxorubicin Against Drug-Resistant Cancer Cells

  2012cites this paper
• Toxic effects of free and DNA-linked daunorubicin on isolated rat cardiac myocytes.

  2009cites this paper
• A combined chemoimmunotherapy approach using a plasmid-doxorubicin complex.

  2009cites this paper
• The immunoinhibitory and immunostimulatory effects of hydroxyanthra- and hydroxynaphthoquinone derivatives

  2008cites this paper
• Plasma levels of doxorubicin after IV bolus injection and infusion of the doxorubicin-DNA complex in rabbits and man

  2004cites this paper
• Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia

  2004cites this paper
• Daunorubicin-DNA and doxorubicin-DNA a review of experimental and clinical data

  2004cites this paper
• Leukemic cell versus plasma levels of Daunorubicin and Daunorubicinol after infusion of Daunorubicin as free drug or the DNA complex

  2004cites this paper
• DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro

  2004cites this paper
• Attenuation of cardiotoxicity of daunomycin using a complex with heparin.

  1996cites this paper
• Passive tumor targeting of soluble macromolecules and drug conjugates.

  1992cites this paper
• Pharmacokinetics of Daunorubicin and Doxorubicin in Plasma and Leukemic Cells from Patients with Acute Nonlymphoblastic Leukemia

  1989cites this paper
• Immunological evaluation of blood contamination in tissue distribution studies.

  1989cites this paper
• Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograft.

  1988cites this paper
• Tissue distribution and myelotoxicity of daunomycin in the rat: rapid bolus injection vs continuous infusion.

  1986cites this paper
• Biological approaches to the controlled delivery of drugs: a critical review.

  1984cites this paper
• Comparative toxicity of adriamycin and adriamycin-DNA in rats.

  1983cites this paper
• Transport and Storage of Anthracyclines in Experimental Systems and Human Leukemia

  1982cites this paper
• Significance of cellular pharmacokinetics for the cytotoxic effects of daunorubicin.

  1982cites this paper
• Receptor mediated endocytosis of hemoglobin-haptoglobin, galactosylated serum albumin and polymeric IgA by the liver.

  1982cites this paper
• Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms.

  1981cites this paper
• Reducing the cardiotoxicity of anthracyclines by complex‐bindin to DNA

  1981cites this paper
• Accumulation, metabolism and subcellular localization of daunorubicin, doxorubicin and their DNA-complexes in rat heart ventricles.

  1981cites this paper
• Effectiveness of the adriamycin-DNA complex in kidney allograft immunosuppression.

  1981cites this paper
• Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex.

  1980cites this paper
• DNA--anthracycline complexes. II. Comparative study of the acute lesions induced in mice after intravenous administration of free and DNA bound adriamycin.

  1980cites this paper
• DNA, liposomes, and proteins as carriers for antitumoral drugs.

  1980cites this paper
• Comparative studies of the accumulation of doxorubicin and doxorubicin-DNA in various cell lines.

  1980cites this paper
• DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.

  1980cites this paper
• Development of selective antitumoral drug-carrier complexes: present status and prospects.

  1979cites this paper
• Effects of daunorubicin and doxorubicin, free and associated with DNA, on hemopoietic stem cells.

  1979cites this paper
• Clinical studies with daunorubicin-DNA and adriamycin-DNA complexes: a review.

  1979cites this paper
• Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin.

  1979cites this paper